Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-08-12 , DOI: 10.1111/apt.16563
Emily Harding-Theobald ₁ , Jeremy Louissaint ₁ , Bharat Maraj ₁ , Edward Cuaresma ₁ , Whitney Townsend ₂ , Mishal Mendiratta-Lala ₃ , Amit G Singal ₄ , Grace L Su ₁ , Anna S Lok ₁ , Neehar D Parikh ₁

Affiliation

Advances in imaging technology have the potential to transform the early diagnosis and treatment of hepatocellular carcinoma (HCC) through quantitative image analysis. Computational “radiomic” techniques extract biomarker information from images which can be used to improve diagnosis and predict tumour biology.

中文翻译：